Arkolith/Insider Trading/ZVRA/Form 4

McFarlane Neil F.

President and CEO, DirectorZEVRA THERAPEUTICS, INC. (ZVRA) · full profile →Form 4 · filed Oct 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$211K
Net Open-Market Flow
-$211K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 10, 2025Option exercise(M)50K——242K
Oct 10, 2025Sell(S)20K$10.82$211K222K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 10, 2025Option exercise(M)50K—$0100K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001681098-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ZEVRA THERAPEUTICS, INC.

Build

Ask your agent about ZVRA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001681098-25-000005"
Ask your agent
Use Arkolith to summarize insider buying and selling at ZEVRA THERAPEUTICS, INC.
over the last 90 days and cite the filings.